Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy?

Transcatheter aortic valve replacement (TAVR) has become an established therapeutic option for patients with symptomatic, severe aortic valve stenosis at increased surgical risk. Antithrombotic therapy after TAVR aims to prevent transcatheter heart valve (THV) thrombosis, in which two different enti...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Cardiovasc Med
Prif Awduron: Rosseel, Liesbeth, De Backer, Ole, Søndergaard, Lars
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2019
Pynciau:
Cardiovascular Medicine
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482296/
https://ncbi.nlm.nih.gov/pubmed/31058168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2019.00044
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg